Clinical Trial Update: A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II exploratory clinical trial evaluating multiple drug combinations for advanced esophageal squamous cell carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING